Regulation of neuroinflammation through programed death-1/programed death ligand signaling in neurological disorders

Frontiers in Cellular Neuroscience

Volumn 8, Issue SEP, 2014, Pages

  Zhao, Shangfeng ^a,b   Li, Fengwu ^c   Leak, Rehana K ^d   Chen, Jun ^a   Hu, Xiaoming ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d DUQUESNE UNIVERSITY   (United States)

Author keywords

Inflammation; Neurodegeneration; PD 1; PD L1; Stroke

Indexed keywords

EID: 84906912954     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00271     Document Type: Review

References (65)

1. Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J. C., Moskowitz, M. A., et al. (2001). Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724-7732.
2. Blank, C., Brown, I., Marks, R., Nishimura, H., Honjo, T., and Gajewski, T. F. (2003). Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells. J. Immunol. 171, 4574-4581. doi: 10. 4049/jimmunol. 171. 9. 4574.
3. Blocki, F. A., Radhakrishnan, S., Van Keulen, V. P., Heckman, K. L., Ciric, B., Howe, C. L., et al. (2006). Induction of a gene expression program in dendritic cells with a cross-linking IgM antibody to the co-stimulatory molecule B7-DC. FASEB J. 20, 2408-2410. doi: 10. 1096/fj. 06-6171fje.
4. Bodhankar, S., Chen, Y., Vandenbark, A. A., Murphy, S. J., and Offner, H. (2013a). IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke. Metab. Brain Dis. 28, 375-386. doi: 10. 1007/s11011-013-9413-3.
5. Bodhankar, S., Chen, Y., Vandenbark, A. A., Murphy, S. J., and Offner, H. (2013b). PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1. J. Neuroinflammation 10, 111. doi: 10. 1186/1742-2094-10-111.
6. Bodhankar, S., Vandenbark, A. A., and Offner, H. (2012). Oestrogen treatment of experimental autoimmune encephalomyelitis requires 17beta-oestradiol-receptor-positive B cells that up-regulate PD-1 on CD4+ Foxp3+ regulatory T cells. Immunology 137, 282-293. doi: 10. 1111/imm. 12013.
7. Bodhankar, S., Wang, C., Vandenbark, A. A., and Offner, H. (2011). Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cells. Eur. J. Immunol. 41, 1165-1175. doi: 10. 1002/eji. 201040992.
8. Brandl, C., Ortler, S., Herrmann, T., Cardell, S., Lutz, M. B., and Wiendl, H. (2010). B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cells. PLoS ONE 5: e10800. doi: 10. 1371/journal. pone. 0010800.
9. Carter, L. L., Leach, M. W., Azoitei, M. L., Cui, J., Pelker, J. W., Jussif, J., et al. (2007). PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 182, 124-134. doi: 10. 1016/j. jneuroim. 2006. 10. 006.
10. Chang, W. S., Kim, J. Y., Kim, Y. J., Kim, Y. S., Lee, J. M., Azuma, M., et al. (2008). Cutting edge: programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy. J. Immunol. 181, 6707-6710. doi: 10. 4049/jimmunol. 181. 10. 6707.
11. Cheng, X., Zhao, Z., Ventura, E., Gran, B., Shindler, K. S., and Rostami, A. (2007). The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma. J. Neuroimmunol. 185, 75-86. doi: 10. 1016/j. jneuroim. 2007. 01. 012.
12. Compston, A., and Coles, A. (2008). Multiple sclerosis. Lancet 372, 1502-1517. doi: 10. 1016/S0140-6736(08)61620-7.
13. Engelhardt, B. (2008). The blood-central nervous system barriers actively control immune cell entry into the central nervous system. Curr. Pharm. Des. 14, 1555-1565. doi: 10. 2174/138161208784705432.
14. Fife, B. T., Pauken, K. E., Eagar, T. N., Obu, T., Wu, J., Tang, Q., et al. (2009). Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat. Immunol. 10, 1185-1192. doi: 10. 1038/ni. 1790.
15. Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., et al. (2000). Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027-1034. doi: 10. 1084/jem. 192. 7. 1027.
16. Gelderblom, M., Leypoldt, F., Steinbach, K., Behrens, D., Choe, C. U., Siler, D. A., et al. (2009). Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 40, 1849-1857. doi: 10. 1161/STROKEAHA. 108. 534503.
17. Ghiotto, M., Gauthier, L., Serriari, N., Pastor, S., Truneh, A., Nunes, J. A., et al. (2010). PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1. Int. Immunol. 22, 651-660. doi: 10. 1093/intimm/dxq049.
18. Guerreiro, R. J., Santana, I., Bras, J. M., Santiago, B., Paiva, A., and Oliveira, C. (2007). Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment. Neurodegener. Dis. 4, 406-412. doi: 10. 1159/000107700.
19. Iadecola, C., and Anrather, J. (2011). The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796-808. doi: 10. 1038/nm. 2399.
20. Joller, N., Peters, A., Anderson, A. C., and Kuchroo, V. K. (2012). Immune checkpoints in central nervous system autoimmunity. Immunol. Rev. 248, 122-139. doi: 10. 1111/j. 1600-065X. 2012. 01136. x.
21. Keir, M. E., Latchman, Y. E., Freeman, G. J., and Sharpe, A. H. (2005). Programmed death-1 (PD-1): PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes. J. Immunol. 175, 7372-7379. doi: 10. 4049/jimmunol. 175. 11. 7372.
22. Koronyo-Hamaoui, M., Ko, M. K., Koronyo, Y., Azoulay, D., Seksenyan, A., Kunis, G., et al. (2009). Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9. J. Neurochem. 111, 1409-1424. doi: 10. 1111/j. 1471-4159. 2009. 06402. x.
23. Kroner, A., Mehling, M., Hemmer, B., Rieckmann, P., Toyka, K. V., Maurer, M., et al. (2005). A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann. Neurol. 58, 50-57. doi: 10. 1002/ana. 20514.
24. Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., et al. (2005). IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233-240. doi: 10. 1084/jem. 20041257.
25. Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., et al. (2001). PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2, 261-268. doi: 10. 1038/85330.
26. Latchman, Y. E., Liang, S. C., Wu, Y., Chernova, T., Sobel, R. A., Klemm, M., et al. (2004). PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. U. S. A. 101, 10691-10696. doi: 10. 1073/pnas. 0307252101.
27. Lee, Y., Moon, Y., Hyung, K., Yoo, J., Lee, M., Lee, I., et al. (2013). Macrophage PD-L1 strikes back: PD-1/PD-L1 interaction drives macrophages toward regulatory subsets. Adv. Biosci. Biotechnol. 4, 19-29. doi: 10. 4236/abb. 2013. 48A3003.
28. Li, P., Gan, Y., Sun, B. L., Zhang, F., Lu, B., Gao, Y., et al. (2013). Adoptive regulatory T-cell therapy protects against cerebral ischemia. Ann. Neurol. 74, 458-471. doi: 10. 1002/ana. 23815.
29. Li, P., Mao, L., Liu, X., Gan, Y., Zheng, J., Thomson, A. W., et al. (2014). Essential role of program death 1-ligand 1 in regulatory T-cell-afforded protection against blood-brain barrier damage after stroke. Stroke 45, 857-864. doi: 10. 1161/STROKEAHA. 113. 004100.
30. Liesz, A., Suri-Payer, E., Veltkamp, C., Doerr, H., Sommer, C., Rivest, S., et al. (2009). Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 15, 192-199. doi: 10. 1038/nm. 1927.
31. Liesz, A., Zhou, W., Mracsko, E., Karcher, S., Bauer, H., Schwarting, S., et al. (2011). Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 134, 704-720. doi: 10. 1093/brain/awr008.
32. Lipp, M., Brandt, C., Dehghani, F., Kwidzinski, E., and Bechmann, I. (2007). PD-L1 (B7-H1) regulation in zones of axonal degeneration. Neurosci. Lett. 425, 156-161. doi: 10. 1016/j. neulet. 2007. 07. 053.
33. Liu, Y. H., Zeng, F., Wang, Y. R., Zhou, H. D., Giunta, B., Tan, J., et al. (2013). Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapies. Drug Discov. Today 18, 1212-1220. doi: 10. 1016/j. drudis. 2013. 07. 020.
34. Minagar, A., Toledo, E. G., Alexander, J. S., and Kelley, R. E. (2004). Pathogenesis of brain and spinal cord atrophy in multiple sclerosis. J. Neuroimaging 14, 5S-10S. doi: 10. 1111/j. 1552-6569. 2004. tb00273. x.
35. Nishimura, H., Nose, M., Hiai, H., Minato, N., and Honjo, T. (1999). Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11, 141-151. doi: 10. 1016/S1074-7613(00)80089-8.
36. Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., et al. (2001). Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291, 319-322. doi: 10. 1126/science. 291. 5502. 319.
37. Okazaki, T., Chikuma, S., Iwai, Y., Fagarasan, S., and Honjo, T. (2013). A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application. Nat. Immunol. 14, 1212-1218. doi: 10. 1038/ni. 2762.
38. Okazaki, T., Maeda, A., Nishimura, H., Kurosaki, T., and Honjo, T. (2001). PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc. Natl. Acad. Sci. U. S. A. 98, 13866-13871. doi: 10. 1073/pnas. 231486598.
39. Pittet, C. L., Newcombe, J., Prat, A., and Arbour, N. (2011). Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis. J. Neuroinflammation 8, 155. doi: 10. 1186/1742-2094-8-155.
40. Probst, H. C., Mccoy, K., Okazaki, T., Honjo, T., and Van Den Broek, M. (2005). Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6, 280-286. doi: 10. 1038/ni1165.
41. Ren, X., Akiyoshi, K., Dziennis, S., Vandenbark, A. A., Herson, P. S., Hurn, P. D., et al. (2011a). Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J. Neurosci. 31, 8556-8563. doi: 10. 1523/JNEUROSCI. 1623-11. 2011.
42. Ren, X., Akiyoshi, K., Vandenbark, A. A., Hurn, P. D., and Offner, H. (2011b). Programmed death-1 pathway limits central nervous system inflammation and neurologic deficits in murine experimental stroke. Stroke 42, 2578-2583. doi: 10. 1161/STROKEAHA. 111. 613182.
43. Reynoso, E. D., Elpek, K. G., Francisco, L., Bronson, R., Bellemare-Pelletier, A., Sharpe, A. H., et al. (2009). Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade. J. Immunol. 182, 2102-2112. doi: 10. 4049/jimmunol. 0802769.
44. Rifa'i, M., Kawamoto, Y., Nakashima, I., and Suzuki, H. (2004). Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J. Exp. Med. 200, 1123-1134. doi: 10. 1084/jem. 20040395.
45. Riley, J. L., and June, C. H. (2005). The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood 105, 13-21. doi: 10. 1182/blood-2004-04-1596.
46. Rosell, A., Ortega-Aznar, A., Alvarez-Sabin, J., Fernandez-Cadenas, I., Ribo, M., Molina, C. A., et al. (2006). Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke37, 1399-1406. doi: 10. 1161/01. STR. 0000223001. 06264. af.
47. Rubio-Perez, J. M., and Morillas-Ruiz, J. M. (2012). A review: inflammatory process in Alzheimer's disease, role of cytokines. ScientificWorldJournal 2012, 756357. doi: 10. 1100/2012/756357.
48. Said, E. A., Dupuy, F. P., Trautmann, L., Zhang, Y., Shi, Y., El-Far, M., et al. (2010). Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat. Med. 16, 452-459. doi: 10. 1038/nm. 2106.
49. Salama, A. D., Chitnis, T., Imitola, J., Ansari, M. J., Akiba, H., Tushima, F., et al. (2003). Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198, 71-78. doi: 10. 1084/jem. 20022119.
50. Saresella, M., Calabrese, E., Marventano, I., Piancone, F., Gatti, A., Calvo, M. G., et al. (2010). PD1 negative and PD1 positive CD4+ T regulatory cells in mild cognitive impairment and Alzheimer's disease. J. Alzheimers Dis. 21, 927-938. doi: 10. 3233/JAD-2010-091696.
51. Saresella, M., Calabrese, E., Marventano, I., Piancone, F., Gatti, A., Farina, E., et al. (2012). A potential role for the PD1/PD-L1 pathway in the neuroinflammation of Alzheimer's disease. Neurobiol. Aging 33, e611-e622. doi: 10. 1016/j. neurobiolaging. 2011. 03. 004.
52. Schreiner, B., Bailey, S. L., Shin, T., Chen, L., and Miller, S. D. (2008). PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE. Eur. J. Immunol. 38, 2706-2717. doi: 10. 1002/eji. 200838137.
53. Sheppard, K. A., Fitz, L. J., Lee, J. M., Benander, C., George, J. A., Wooters, J., et al. (2004). PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta. FEBS Lett. 574, 37-41. doi: 10. 1016/j. febslet. 2004. 07. 083.
54. Speciale, L., Calabrese, E., Saresella, M., Tinelli, C., Mariani, C., Sanvito, L., et al. (2007). Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients. Neurobiol. Aging 28, 1163-1169. doi: 10. 1016/j. neurobiolaging. 2006. 05. 020.
55. Torres, K. C., Araujo Pereira, P., Lima, G. S., Bozzi, I. C., Rezende, V. B., Bicalho, M. A., et al. (2013). Increased frequency of T cells expressing IL-10 in Alzheimer disease but not in late-onset depression patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 47, 40-45. doi: 10. 1016/j. pnpbp. 2013. 07. 021.
56. Trabattoni, D., Saresella, M., Pacei, M., Marventano, I., Mendozzi, L., Rovaris, M., et al. (2009). Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease. J. Immunol. 183, 4984-4993. doi: 10. 4049/jimmunol. 0901038.
57. Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M., et al. (2008). Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172, 146-155. doi: 10. 2353/ajpath. 2008. 070690.
58. Viglietta, V., Baecher-Allan, C., Weiner, H. L., and Hafler, D. A. (2004). Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199, 971-979. doi: 10. 1084/jem. 20031579.
59. Wang, C., Li, Y., Proctor, T. M., Vandenbark, A. A., and Offner, H. (2010). Down-modulation of programmed death 1 alters regulatory T cells and promotes experimental autoimmune encephalomyelitis. J. Neurosci. Res. 88, 7-15. doi: 10. 1002/jnr. 22181.
60. Yilmaz, G., Arumugam, T. V., Stokes, K. Y., and Granger, D. N. (2006). Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 113, 2105-2112. doi: 10. 1161/CIRCULATIONAHA. 105. 593046.
61. Yokosuka, T., Takamatsu, M., Kobayashi-Imanishi, W., Hashimoto-Tane, A., Azuma, M., and Saito, T. (2012). Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J. Exp. Med. 209, 1201-1217. doi: 10. 1084/jem. 20112741.
62. Zhang, X., Schwartz, J. C., Guo, X., Bhatia, S., Cao, E., Lorenz, M., et al. (2004). Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity 20, 337-347. doi: 10. 1016/S1074-7613(04)00051-2.
63. Zhong, X., Tumang, J. R., Gao, W., Bai, C., and Rothstein, T. L. (2007). PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding. Eur. J. Immunol. 37, 2405-2410. doi: 10. 1002/eji. 200737461.
64. Zhu, B., Guleria, I., Khosroshahi, A., Chitnis, T., Imitola, J., Azuma, M., et al. (2006). Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. J. Immunol. 176, 3480-3489. doi: 10. 4049/jimmunol. 176. 6. 3480.
65. Zipp, F., and Aktas, O. (2006). The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci. 29, 518-527. doi: 10. 1016/j. tins. 2006. 07. 006.